Skip to main content
Premium Trial:

Request an Annual Quote

Labs Fournier to Use Temis' Text Mining Software for Biomarker Research

NEW YORK (GenomeWeb News) – Software maker Temis said today that Laboratoires Fournier, a drug discovery affiliate of Solvay Pharmaceuticals, will use Temis’ Luxid text analytic solution.
 
Laboratoires Fournier will use the software in its Exploratory Biology Unit, which searches for biomarkers that could be used in Solvay’s pre-clinical drug development programs.
 
Temis said it began a partnership with Laboratoires Fournier in 2005 that involved using Luxid for synthesis of biological, medical, and chemical information, and that it now plans to develop an information extraction tool for discovering biomarkers.
 
Financial terms of the agreement were not released.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.